| For: | Improta-Caria AC, Ferrari F, Gomes JLP, Villalta PB, Soci ÚPR, Stein R, Oliveira EM. Dysregulated microRNAs in type 2 diabetes and breast cancer: Potential associated molecular mechanisms. World J Diabetes 2024; 15(6): 1187-1198 [PMID: 38983808 DOI: 10.4239/wjd.v15.i6.1187] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i6/1187.htm |
| Number | Citing Articles |
| 1 |
Federica Tambaro, Simona Orlando, Giovanni Imbimbo, Alessandro De Luca, Rossella Melcarne, Maria Ida Amabile, Maurizio Muscaritoli, Alessio Molfino. Circulating MicroRNAs Reflect Body Composition Features in Newly Diagnosed Breast Cancer. International Journal of Molecular Sciences 2026; 27(16) doi: 10.3390/ijms27167098
|
| 2 |
Iman Mohammad Said Jallod, Ammar Khalo Abbas, Faheemah Ismael Yaqoob, Abdul-Aziz Ahmed Aziz. Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(11) doi: 10.1007/s00210-025-04209-5
|
| 3 |
Yuhan Bai, Xiangyi Kong, Jing Wang. Targeting microbiome-driven epigenetic modifications: a new frontier in breast cancer treatment. Clinical Epigenetics 2026; 18(1) doi: 10.1186/s13148-025-02046-0
|
| 4 |
Md. Sadikuj Jaman, Md. Maniruzzaman, Md. Rokibul Hasan Bhuiyan, Md Shajedul Haque, Irfan Ahmad. The Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products. International Journal of Breast Cancer 2026; 2026(1) doi: 10.1155/ijbc/2576658
|
| 5 |
I.A. Durrani, P. John, A. Bhatti. Networking Salt Inducible Kinase 1 Regulatory Perturbations on Type 2 Diabetes- Breast Cancer Co-Morbidity Associated Molecular Bridge. The EuroBiotech Journal 2025; 9(1) doi: 10.2478/ebtj-2025-0008
|
| 6 |
Hadeer M. Morsy, Mohamed Y. Zaky, Osama M. Ahmed. MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy. Advances in Biochemistry in Health and Disease 2026; 34 doi: 10.1007/978-3-032-08824-6_20
|